SACRAMENTO—Yesterday Governor Brown signed AB 2229, one of several bills Assemblymember Jim Wood (D-Santa Rosa) has introduced to address the many challenges residents have experienced related to California’s wildfires and the rebuilding process.
SACRAMENTO–On June 25, the U.S. Food and Drug Administration (FDA) issued approval of a new drug, Epidiolex, to treat seizures associated with two severe childhood-onset epilepsies, Lennox-Gastaut syndrome or Dravet syndrome. Epidiolex is the first prescription, plant-derived cannabinoid (CBD) in the category of anti-epileptic drugs and has been approved to treat children two years of age or older.
“That was great news but we discovered a problem that would have prohibited patients from receiving it,” said Assemblymember Jim Wood (D-Santa Rosa). “Prior to this bill, any product that contained CBD was considered a Schedule I Controlled Substance under California statute, and because of that doctors wouldn’t be allowed to prescribe it, but AB 710 fixes that.”
Sacramento, CA – North Coast legislators Assemblymember Jim Wood and Senator Mike McGuire are pleased the North Coast Regional Office of the Bureau of Cannabis Control is open for business starting today, providing a one-stop shop for local residents to do business with the state.
Deal struck between the beverage industry and SEIU is handed off to Legislature
SACRAMENTO–Today the Assembly and Senate voted on a budget bill, AB 1838, which was handed off to them as the result of an outside deal struck between the beverage industry and the Service Employees International Union (SEIU).
Governor’s signature will allow patients to receive newly approved drug for epilepsy
Local environmental groups express support
SACRAMENTO–Today Assemblymember Jim Wood (D-Santa Rosa) cast his vote in support of California’s 2018-19 State Budget. “The budget continues to be a good news, bad news story,” said Wood.
